Vimarsana
Biggest News Aggregation in the World

Page 2 - Head Clinical Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Head Clinical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Head Clinical Development Today - Breaking & Trending Today

Themis Medicare receives approval of antiviral drug VIRALEX from Drug Controller General of India - Vimarsana News

Themis Medicare receives approval of antiviral drug VIRALEX from Drug Controller General of India

Published: March 4, 2022

Viralex has been found to be effective and well-tolerated in mild to moderate COVID-19, in two Randomized Controlled Clinical Trials conducted on 499 Indian patients.

Source: indiainfoline.com
Related Topics:
Inosine PranobexSachin PatelRaja DharAshok SwainHead Of Department PulmonologyThemis Medicare LtdHead Clinical DevelopmentThemis MedicareThemis Medicare LimitedDrug Controller GeneralPlacebo Controlled TrialMulticentre TrialManaging Director
SaNOtize Research & Development Corp.: Phase 3 Clinical Trial Confirms SaNOtize's Breakthrough Treatment is 99% Effective Against COVID-19; Receives Regulatory Approval in India - Vimarsana News

SaNOtize Research & Development Corp.: Phase 3 Clinical Trial Confirms SaNOtize's Breakthrough Treatment is 99% Effective Against COVID-19; Receives Regulatory Approval in India

Published: February 9, 2022

Phase 3 trial reached primary endpoint and demonstrated a reduction in SARS-CoV-2 log viral load in COVID-19 patients by more than 94% within 24 hours of treatment, and by more than 99% in 48 hours

Source: finanznachrichten.de
Related Topics:
Hong KongUnited KingdomBritish ColumbiaRepublic OfEast TimorSri LankaUnited Kingdom GeneralMartin CejChris MillerKostenloser WertpapierhandelUdaykumar MurthyMonika TandonGilly RegevSanotize CoHead Clinical DevelopmentWorld Health OrganizationSanotize Research Development CorpPublic AffairsCorporate CommunicationsGlenmark Pharmaceuticals LimitedLongview CommunicationsCompany RankingsGlenmark Pharmaceuticals LtdSurrey Pathology ServicesNitric Oxide Nasal Spray